Cantor Fitzgerald analyst Steve Seehouse downgraded Korro Bio Inc. (NASDAQ: KRRO) from Overweight to Neutral.The analyst comments: "Korro's lead AATD ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE